Concepedia

Michal Geva

MG

Statistics

Publications

24

Citations

1.3K

H-Index

22

Active since

2010

Affiliations

University of British Columbia(Current)

Teva Pharmaceuticals (Israel)

BC Children's Hospital

Tel Aviv University

Immuneering (United States)

Michal Geva is an author at University of British Columbia specializing in neuroscience, neurodegenerative diseases, and neurodegenerative disorders.

Publications per year

2010–2025

24

Publications

24

Drug resistance confounding prion therapeutics

David B. Berry, Duo Lü, Michal Geva et al. · Proceedings of the National Academy of Sciences · 2013 · 160 citations · Full text

Life Sciences, Neuroscience, Pharmacology +16

The sigma-1 receptor mediates the beneficial effects of pridopidine in a mouse model of Huntington disease

Daniel A. Ryskamp, Jun Wu, Michal Geva et al. · Neurobiology of Disease · 2016 · 128 citations · Full text

Life Sciences, Neuroscience, Pharmacology +14

Targeting the Sigma-1 Receptor via Pridopidine Ameliorates Central Features of ALS Pathology in a SOD1G93A Model

Ariel Ionescu, Tal Gradus, Topaz Altman et al. · Cell Death and Disease · 2019 · 89 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Pridopidine activates neuroprotective pathways impaired in Huntington Disease

Michal Geva, Rebecca Kusko, Holly Soares et al. · Human Molecular Genetics · 2016 · 79 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

A mouse model for eukaryotic translation initiation factor 2B-leucodystrophy reveals abnormal development of brain white matter

Michal Geva, Yuval Cabilly, Yaniv Assaf et al. · Brain · 2010 · 74 citations

Life Sciences, Genetics, Neuroscience +17

1–5 of 24